-
Oppenheimer Appoints Vien Le As Managing Director
-
Oppenheimer Holdings (OPY) Reports Q4 EPS of $6.51
-
Oppenheimer hires Kostas Biliouris as biotech research managing director
-
Oppenheimer appoints Keith Peterson as head of cash equity sales and trading
-
Oppenheimer Holdings (OPY) Reports Q3 EPS of $1.90
-
Oppenheimer hires Guy Logan as managing director for public finance unit
-
Oppenheimer expands custody platform with fixed income integration
-
Oppenheimer Holdings (OPY) Reports Q2 EPS of $1.91
-
Oppenheimer names Jon Hudson co-head of healthcare services banking
-
Oppenheimer Holdings (OPY) Reports Q1 EPS of $2.72
-
Oppenheimer Holdings (OPY) Reports Q4 EPS of $0.92
-
Oppenheimer Holdings (OPY) Reports Q3 EPS of $2.16
-
Oppenheimer (OPY) Appoints Christian Baetz as Managing Director, Consumer Investment Banking
-
Oppenheimer Holdings (OPY) Reports Q2 EPS of $0.92
-
Oppenheimer Holdings (OPY) Appoints Andreas Argyrides as Executive Director and Senior Analyst Covering the Biotechnology Sector
-
Oppenheimer (OPY) Appoints Rayna Kumar as Managing Director and Senior Analyst of the Fintech Sector
-
Oppenheimer (OPY) Appoints Kunal Bhatia as Managing Director, Healthcare Investment Banking

